Literature DB >> 10896777

Induction of M-phase arrest and apoptosis after HIV-1 Vpr expression through uncoupling of nuclear and centrosomal cycle in HeLa cells.

N Watanabe1, T Yamaguchi, Y Akimoto, J B Rattner, H Hirano, H Nakauchi.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces cell cycle arrest in the G2 phase of the cell cycle followed by apoptosis. The mechanism of the arrest is unknown but the arrest is believed to facilitate viral replication. In the present study, we have established cell lines that allow conditional expression of Vpr, and have examined the mechanism of cell death following Vpr expression. We found that cells expressing Vpr enter M phase after long G2 arrest but formed aberrant multipolar spindles that were incapable of completing karyokinesis or cytokinesis. This abnormality provided the basis for apoptosis, which always followed in these cells. The multipolar spindles formed in response to abnormal centrosomal duplication that occurred during the G2 arrest but did not occur in cells arrested in G2 by irradiation. Thus, the expression of Vpr appears to be responsible for abnormal centrosome duplication, which in turn contributes in part to the rapid cell death following HIV-1 infection. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10896777     DOI: 10.1006/excr.2000.4908

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  19 in total

1.  Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis.

Authors:  Huidong Yuan; Yi-Ming Xie; Irvin S Y Chen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Different apoptotic responses and patterns in adhering and floating neoplastic cell cultures: effects of microtubule antagonists.

Authors:  Luigi Sciola; Alessandra Spano; Gianni Monaco; Maria Grazia Bottone; Sergio Barni
Journal:  Histochem Cell Biol       Date:  2002-12-20       Impact factor: 4.304

Review 3.  Such small hands: the roles of centrins/caltractins in the centriole and in genome maintenance.

Authors:  Tiago J Dantas; Owen M Daly; Ciaran G Morrison
Journal:  Cell Mol Life Sci       Date:  2012-03-30       Impact factor: 9.261

4.  Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes.

Authors:  Y Zhu; H A Gelbard; M Roshal; S Pursell; B D Jamieson; V Planelles
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  HIV-1 viral protein R downregulates Ebp1 and stabilizes p53 in glioblastoma U87MG cells.

Authors:  S Zhang; B Zhang; X Xu; L Wang; X Feng; Q Wang; H Huang; J Wu; P Li; J Wang
Journal:  Clin Transl Oncol       Date:  2013-07-05       Impact factor: 3.405

6.  HIV-1 Vpr hijacks EDD-DYRK2-DDB1DCAF1 to disrupt centrosome homeostasis.

Authors:  Delowar Hossain; Jérémy A Ferreira Barbosa; Éric A Cohen; William Y Tsang
Journal:  J Biol Chem       Date:  2018-05-03       Impact factor: 5.157

7.  Human immunodeficiency virus type 1 Vpr binds to the N lobe of the Wee1 kinase domain and enhances kinase activity for CDC2.

Authors:  Masakazu Kamata; Nobumoto Watanabe; Yoshiko Nagaoka; Irvin S Y Chen
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

Review 8.  Macrophage signaling in HIV-1 infection.

Authors:  Georges Herbein; Gabriel Gras; Kashif Aziz Khan; Wasim Abbas
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

9.  A centrosome-autonomous signal that involves centriole disengagement permits centrosome duplication in G2 phase after DNA damage.

Authors:  Burcu Inanç; Helen Dodson; Ciaran G Morrison
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

10.  HIV-1 Vpr induces defects in mitosis, cytokinesis, nuclear structure, and centrosomes.

Authors:  Fred Chang; Fabio Re; Sarah Sebastian; Shelley Sazer; Jeremy Luban
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.